Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: RISK OF VENOUS THROMBOEMBOLISM, . Treffer: 16
2023
Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31
Doi: 10.1016/j.clgc.2022.10.005
Web of Science
PubMed
FullText
FullText_MUG
2022
COVIDSurg Collaborative;GlobalSurg Collaborative
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Anaesthesia. 2022; 77(1): 28-39.
Doi: 10.1111/anae.15563
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Harris, K; Laws, JM; Elias, A; Green, DA; Goswami, N; Jordan, J; Kamine, TH; Mazzolai, L; Petersen, LG; Winnard, AJ; Weber, T
Search for Venous Endothelial Biomarkers Heralding Venous Thromboembolism in Space: A Qualitative Systematic Review of Terrestrial Studies.
Front Physiol. 2022; 13:885183
Doi: 10.3389/fphys.2022.885183
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Patel, R; Woo, K; Wakefield, TW; Beaulieu, RJ; Khashram, M; De, Caridi, G; Benedetto, F; Shalhub, S; El-Ghazali, A; Silpe, JE; Rosca, M; Cohnert, TU; Siegl, GK; Abularrage, C; Sorber, R; Wittgen, CM; Bove, PG; Long, GW; Charlton-Ouw, KM; Ray, HM; Lawrence, P; Baril, D
Contemporary management and outcomes of peripheral venous aneurysms: A multi-institutional study.
J Vasc Surg Venous Lymphat Disord. 2022; 10(6):1352-1358
Doi: 10.1016/j.jvsv.2022.06.011
Web of Science
PubMed
FullText
FullText_MUG
2021
Hisada, Y; Garratt, KB; Maqsood, A; Grover, SP; Kawano, T; Cooley, BC; Erlich, J; Moik, F; Flick, MJ; Pabinger, I; Mackman, N; Ay, C
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.
Blood Adv. 2021; 5(2):487-495
Doi: 10.1182/bloodadvances.2020003149
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moik, F; Chan, WE; Wiedemann, S; Hoeller, C; Tuchmann, F; Aretin, MB; Fuereder, T; Zöchbauer-Müller, S; Preusser, M; Pabinger, I; Ay, C
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Blood. 2021; 137(12):1669-1678
Doi: 10.1182/blood.2020007878
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moik, F; Prager, G; Thaler, J; Posch, F; Wiedemann, S; Schramm, T; Englisch, C; Mackman, N; Pabinger, I; Ay, C
Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Arterioscler Thromb Vasc Biol. 2021; 41(11): 2837-2847.
Doi: 10.1161/ATVBAHA.121.316463
Web of Science
PubMed
FullText
FullText_MUG
2020
Moik, F; Posch, F; Grilz, E; Scheithauer, W; Pabinger, I; Prager, G; Ay, C
Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
Thromb Res. 2020; 187:9-17
Doi: 10.1016/j.thromres.2020.01.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moik, F; van, Es, N; Posch, F; Di, Nisio, M; Fuereder, T; Preusser, M; Pabinger, I; Ay, C
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study.
Cancers (Basel). 2020; 12(9):
Doi: 10.3390/cancers12092493
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Mulder, FI; Candeloro, M; Kamphuisen, PW; Di Nisio, M; Bossuyt, PM; Guman, N; Smit, K; Büller, HR; van Es, N; CAT-prediction collaborators
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Haematologica. 2019; 104(6): 1277-1287.
Doi: 10.3324/haematol.2018.209114
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Pabinger, I; van Es, N; Heinze, G; Posch, F; Riedl, J; Reitter, EM; Di Nisio, M; Cesarman-Maus, G; Kraaijpoel, N; Zielinski, CC; Büller, HR; Ay, C
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Lancet Haematol. 2018; 5(7): e289-e298-e289-e298.
Doi: 10.1016/S2352-3026(18)30063-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Königsbrügge, O; Posch, F; Riedl, J; Reitter, EM; Zielinski, C; Pabinger, I; Ay, C
Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
Oncologist. 2016; 21(2):252-257
Doi: 10.1634/theoncologist.2015-0284
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Posch, F; Thaler, J; Zlabinger, GJ; Königsbrügge, O; Koder, S; Zielinski, C; Pabinger, I; Ay, C
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Clin Cancer Res. 2016; 22(1):200-206
Doi: 10.1158/1078-0432.CCR-14-3358
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Lötsch, F; Königsbrügge, O; Posch, F; Zielinski, C; Pabinger, I; Ay, C
Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
Thromb Res. 2014; 134(5): 1008-1013.
Doi: 10.1016/j.thromres.2014.09.001
Web of Science
PubMed
FullText
FullText_MUG
Pabinger, I; Posch, F
Flamethrowers: blood cells and cancer thrombosis risk.
Hematology Am Soc Hematol Educ Program. 2014; 2014(1): 410-417.
Doi: 10.1182/asheducation-2014.1.410
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Papay, P; Miehsler, W; Tilg, H; Petritsch, W; Reinisch, W; Mayer, A; Haas, T; Kaser, A; Feichtenschlager, T; Fuchssteiner, H; Knoflach, P; Vogelsang, H; Platzer, R; Tillinger, W; Jaritz, B; Schmid, A; Blaha, B; Dejaco, C; Sobala, A; Weltermann, A; Eichinger, S; Novacek, G
Clinical presentation of venous thromboembolism in inflammatory bowel disease.
J Crohns Colitis. 2013; 7(9):723-729
Doi: 10.1016/j.crohns.2012.10.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG